All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
HMHA1 (Histocompatibility (Minor) HA-1) is a Protein Coding gene. Among its related pathways are Signaling by GPCR and Rho GTPase cycle. GO annotations related to this gene include GTPase activator activity. An important paralog of this gene is ARHGAP19.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-L039 | Human anti-HMHA1 (VLHDDLLEA) T Cell Receptor, pMP71 | Human | VLHDDLLEA | HLA-A2 | retroviral vector | |||
TCR-L038Z | Human anti-HA-1 (VLHDDLLEA) T cell receptor (Codon optimized and cysteine modified), pCDTCR1 | Human | VLHDDLLEA | HLA-A2 | Lentiviral | |||
TCR-C093Z | Human anti-HA-1 T cell receptor (HA1.M7), pCDTCR1 | Human | HA1.M7 | Human | VLHDDLLEA | HLA-A*0201 | Lentiviral | |
TCR-C094Z | Human anti-HA-1 T cell receptor (KP7), pCDTCR1 | Human | KP7 | Human | VLHDDLLEA | HLA-A2 | Lentiviral | |
TCR-C095Z | Human anti-HA-1 T cell receptor (3HA15), pCDTCR1 | Human | 3HA15 | Human | VLHDDLLEA | HLA-A2 | Lentiviral | |
TCR-C096Z | Human anti-HA-1 T cell receptor (5W38), pCDTCR1 | Human | 5W38 | Human | VLHDDLLEA | HLA-A2 | Lentiviral | |
XS-0623-LX1 | Anti-HA-1 (PD1/28-#1 TCR) T cell receptor, pCDTCR1 Vector | Human | #1 | Human | VLHDDLLEA | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION